Rhythm Pharmaceuticals, Inc. (RYTM) Stock Analysis
Free AI-powered analysis and research for Rhythm Pharmaceuticals, Inc. stock
Sector: Healthcare
Full RYTM report
Rhythm Pharmaceuticals, Inc. (RYTM) is listed in the Healthcare sector. The snapshot on this page updates daily; run a full report for the complete breakdown.
Analyze RYTM Now βπ° Latest Update
Rhythm Pharmaceuticals stock surges 28% on AstraZeneca bid report
Wed, November 4, 2026 at 9:53 PM UTC 4 min read
Rhythm Pharmaceuticals (NASDAQ) shares jumped 28% after The Wall Street Journal reported that AstraZeneca (NASDAQ) made a $10 billion acquisition offer for the company, proposing $124 per share. Following the news, Rhythm's stock closed at $110.68, raising its market capitalization to approximately $7.7 billion. The acquisition would enhance AstraZeneca's portfolio in rare disease treatments, as Rhythm focuses on therapies for rare metabolic disorders.